A BGI Americas official recently outlined some previously undisclosed projects and provided updates on ongoing initiatives ranging from disease-related sequencing to de novo assembly of model organisms.
"Given the essential role of microbes for life on our planet, and our lack of understanding of their complexity and diversity, it is critical that we conquer this unknown frontier," BGI's president said in a statement.
Researchers from China, Denmark, and the UK used high-throughput sequencing to identify and characterize methylation sites in mononuclear peripheral blood cells from an Asian man whose genome was sequenced for a previous study.
BGI and OpGen believe that OpGen’s optical mapping technology will complement next-generation sequencing in order to "enable the efficient and accurate finishing of assembled contigs into chromosomes."
Researchers presented an outline of the project goals and methods at the American Society for Human Genetics meeting last week. The scientists are currently analyzing the data and hope to obtain first results within a few months.
At the ASHG meeting in Washington, DC, researchers from the LuCAMP consortium described their exome sequencing and genotyping approach for finding lower frequency variants linked to conditions such as type 2 diabetes and heart disease.